Qingqiao K. Song
Beijing, 100053, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Real-world safety profile of fezolinetant: a disproportionality analysis based on the FAERS database.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: June 05, 2026
Correction: Real-World Effectiveness and Safety of Liuwei Dihuang Pill for Menopausal Syndrome: Protocol for a Prospective, Observational, Multicenter Cohort Study.
Journal: JMIR research protocols
Published: April 02, 2026
Integrating untargeted metabolomics and machine learning to reveal an aberration of sphingolipid metabolism in cardiometabolic HFpEF.
Journal: Diabetology & metabolic syndrome
Published: March 23, 2026
Defective efferocytosis links autonomic dysfunction and atrial fibrillation: multi-omics integration and in vivo validation.
Journal: Frontiers in immunology
Published: February 27, 2026
A Cross-Layer Inflammatory Signature Links Residual Inflammatory Risk to Heart Failure Risk in Metabolic Syndrome: Network Mapping and Brown Adipose Transcriptomic Support.
Journal: Journal of inflammation research
Published: January 25, 2026
Inflammatory-lipid residual risk phenotypes delineate the HFpEF probability spectrum independent of cardiometabolic mediation.
Journal: BMC cardiovascular disorders
Published: January 22, 2026
A pragmatic nomogram using routinely collected clinical variables to screen prevalent HFpEF: development and temporal validation.
Journal: BMC cardiovascular disorders
Published: January 09, 2026
Real-World Effectiveness and Safety of Liuwei Dihuang Pill for Menopausal Syndrome: Protocol for a Prospective, Observational, Multicenter Cohort Study.
Journal: JMIR research protocols
Published: September 25, 2025
Research progress in mechanism of action and clinical effect of exercise therapy on psycho-cardiological disease
Journal: Zhonghua nei ke za zhi
Published: September 04, 2025
Integrative UHPLC-HRMS and computational biology reveal ferroptosis and anoikis targeting by Wenpitongluo decoction in cardiorenal syndrome.
Journal: Frontiers in chemistry
Published: April 24, 2025
Lingguizhugan decoction ameliorates renal injury secondary to heart failure by improving pyroptosis through TLR4/NF-KB/IRE1α pathway.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: December 21, 2024
Last Updated: 09/26/2026